131 related articles for article (PubMed ID: 3137397)
1. Interleukin 2 activity in peripheral blood mononuclear cells of patients with gynecologic malignancies.
Kikuchi Y; Kita T; Oomori K; Miyauchi M; Iwano I; Kizawa I
Med Oncol Tumor Pharmacother; 1988; 5(2):85-90. PubMed ID: 3137397
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 activity and the response of peripheral blood lymphocytes in patients with gynecologic malignancies.
Iwano I; Kikuchi Y; Oomori K; Kizawa I; Kita T; Kato K
Cancer Detect Prev; 1988; 12(1-6):583-8. PubMed ID: 3263201
[TBL] [Abstract][Full Text] [Related]
3. Effects of PSK on interleukin-2 production by peripheral lymphocytes of patients with advanced ovarian carcinoma during chemotherapy.
Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Kato K
Jpn J Cancer Res; 1988 Jan; 79(1):125-30. PubMed ID: 3128500
[TBL] [Abstract][Full Text] [Related]
4. Proliferation, interleukin-2 production and receptor expression in peripheral blood mononuclear cells from colorectal cancer patients.
Chang KJ; Wang SM; Lee CS; Hsieh KH; Chen KM
J Formos Med Assoc; 1990 Mar; 89(3):205-13. PubMed ID: 1974593
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-2 (IL-2) in cancer-related immune deficiency: in vitro response to IL-2, production of IL-2, and IL-2 receptor expression in patients with advanced cancer.
Mantovani G; Coiana A; Massidda A; Proto E; Floris C; Macciò A; Pusceddu G; Del Giacco GS
Cancer Detect Prev; 1988; 12(1-6):149-59. PubMed ID: 3263194
[TBL] [Abstract][Full Text] [Related]
6. IL 2 alone is mitogenic only for Tac-positive lymphocytes in human peripheral blood.
Taylor DS; Kern JA; Nowell PC
J Immunol; 1986 Mar; 136(5):1620-4. PubMed ID: 3005396
[TBL] [Abstract][Full Text] [Related]
7. Regulatory effects of cytokines and cyclosporine A on peripheral blood mononuclear cells from stable multiple sclerosis patients.
Guillen C; Prieto A; Alvarez-Cermeño JC; de la Piedra M; Gimeno A; Alvarez-Mon M
Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):527-49. PubMed ID: 10466078
[TBL] [Abstract][Full Text] [Related]
8. Medroxyprogesterone acetate reduces the in vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients.
Mantovani G; Macciò A; Esu S; Lai P; Santona MC; Massa E; Dessì D; Melis GB; Del Giacco GS
Eur J Cancer; 1997 Apr; 33(4):602-7. PubMed ID: 9274442
[TBL] [Abstract][Full Text] [Related]
9. Serum immunosuppressive substance in patients with gynecologic malignancies and in pregnant women.
Yamashita K; Hayashi H; Mure K; Ishikawa M; Shimizu T
Cancer; 1986 Jan; 57(1):69-74. PubMed ID: 3940624
[TBL] [Abstract][Full Text] [Related]
10. Reduced LAK cytotoxicity of peripheral blood mononuclear cells in patients with bladder cancer: decreased LAK cytotoxicity caused by a low incidence of CD56+ and CD57+ mononuclear blood cells.
Hermann GG; Petersen KR; Steven K; Zeuthen J
J Clin Immunol; 1990 Nov; 10(6):311-20. PubMed ID: 1707414
[TBL] [Abstract][Full Text] [Related]
11. Suppression of IL-2 production by cryopreserved peripheral blood mononuclear cells from patients with active visceral leishmaniasis in Sicily.
Cillari E; Liew FY; Lo Campo P; Milano S; Mansueto S; Salerno A
J Immunol; 1988 Apr; 140(8):2721-6. PubMed ID: 3258620
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of gold sodium thiomalate on IL-1, IL-2 production, IL-2 receptor expression and IL-2 responsiveness in thymocytes and peripheral blood mononuclear cells.
Blitstein-Willinger E; Streller A
Clin Exp Immunol; 1987 May; 68(2):357-65. PubMed ID: 3115645
[TBL] [Abstract][Full Text] [Related]
13. Effects of cimetidine on interleukin-2 production by peripheral blood lymphocytes in advanced ovarian carcinoma.
Kikuchi Y; Kizawa I; Oomori K; Iwano I; Kita T; Miyauchi M; Kato K
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1185-90. PubMed ID: 3138120
[TBL] [Abstract][Full Text] [Related]
14. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive acidic protein in patients with gynecologic cancer.
Sawada M; Okudaira Y; Matsui Y; Shimizu Y
Cancer; 1984 Aug; 54(4):652-6. PubMed ID: 6744202
[TBL] [Abstract][Full Text] [Related]
16. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection.
Lyons A; Kelly JL; Rodrick ML; Mannick JA; Lederer JA
Ann Surg; 1997 Oct; 226(4):450-8; discussion 458-60. PubMed ID: 9351713
[TBL] [Abstract][Full Text] [Related]
17. The role of prostaglandin E2 in immune suppression following injury.
Grbic JT; Mannick JA; Gough DB; Rodrick ML
Ann Surg; 1991 Sep; 214(3):253-62; discussion 262-3. PubMed ID: 1929607
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
[TBL] [Abstract][Full Text] [Related]
19. Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.
Ozerol I; Ageitos A; Heimann DG; Talmadge JE
Int J Immunopharmacol; 1999 Aug; 21(8):509-21. PubMed ID: 10458540
[TBL] [Abstract][Full Text] [Related]
20. Immunological status of patients subjected to cardiac surgery: serum levels of interleukin 6 and tumor necrosis factor alpha and the ability of peripheral blood mononuclear cells to proliferate and produce these cytokines in vitro.
Właszczyk A; Adamik B; Durek G; Kübler A; Zimecki M
Arch Immunol Ther Exp (Warsz); 1996; 44(4):225-34. PubMed ID: 9017162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
